In vitro comparative activity of the new beta-lactamase inhibitor taniborbactam with cefepime or meropenem against Klebsiella pneumoniae and cefepime against Pseudomonas aeruginosa metallo-beta-lactamase-producing clinical isolates-Reference-Cited by-同舟云学术

In vitro comparative activity of the new beta-lactamase inhibitor taniborbactam with cefepime or meropenem against Klebsiella pneumoniae and cefepime against Pseudomonas aeruginosa metallo-beta-lactamase-producing clinical isolates

Published:2021-11 Issue:5 Volume:58 Page:106440
ISSN:0924-8579
Container-title:International Journal of Antimicrobial Agents
language:en
Short-container-title:International Journal of Antimicrobial Agents

Author:

Meletiadis Joseph^ORCID,Paranos Paschalis,Georgiou Panagiota-Christina,Vourli Sofia,Antonopoulou Stavroula,Michelaki Aikaterini,Vagiakou Eleni,Pournaras Spyros

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine

Reference22 articles.

1. The emergence and implications of metallo-β-lactamases in Gram-negative bacteria;Walsh;Clin Microbiol Infect Suppl,2005

2. Metallo-β-lactamases in Gram-negative bacteria: introducing the era of pan-resistance?;Maltezou;Int J Antimicrob Agents,2009

3. New carbapenemase inhibitors: Clearing the way for the β-lactams;Vázquez-Ucha;Int J Mol Sci,2020

4. Aztreonam plus clavulanate, tazobactam, or avibactam for treatment of infections caused by metallo-lactamase-producing gram-negative bacteria;Emeraud;Antimicrob Agents Chemother,2019

5. Carbapenemases: the versatile beta-lactamases;Queenan;Clin Microbiol Rev,2007

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetics and pharmacodynamics of bacteriophage therapy: a review with a focus on multidrug-resistant Gram-negative bacterial infections;Clinical Microbiology Reviews;2024-09-12

2. A single-layer spot assay for easy, fast, and high-throughput quantitation of phages against multidrug-resistant Gram-negative pathogens;Journal of Clinical Microbiology;2024-08-14

3. Assessment of in vitro activity of ceftazidime/avibactam on carbapenemase‐producing Enterobacterales from Iran: An experimental study;Health Science Reports;2024-08

4. New Agents Are Coming, and So Is the Resistance;Antibiotics;2024-07-13

5. Evolving resistance landscape in gram‐negative pathogens: An update on β‐lactam and β‐lactam‐inhibitor treatment combinations for carbapenem‐resistant organisms;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2024-07